The Antimetabolite Tiazofurin (TR) Inhibits Glycoconjugate Biosynthesis and Invasiveness of Tumour Cells

European Journal of Cancer

Volumn 32, Issue 1, 1996, Pages 152-159

  Timar J ^a   Tovari J ^a   Pogany G ^a   Ladanyi A ^a   Paku, S ^a   Raso E ^a   Bocsi, J ^a   Jeney, A ^a   Lapis, K ^a  

^a SEMMELWEIS UNIVERSITY OF MEDICINE   (Hungary)

Author keywords

3LL carcinoma; Glycoconjugates; Human melanoma; Integrin; Metastasis; MMP2; Tiazofurin

Indexed keywords

ANTIMETABOLITE; GLYCOCONJUGATE; INTEGRIN; METALLOPROTEINASE 2; TIAZOFURIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL INVASION; CONTROLLED STUDY; HUMAN; HUMAN CELL; LUNG CARCINOMA; MELANOMA CELL; METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL;

AMINO ACID SEQUENCE; ANIMALS; ANTIMETABOLITES, ANTINEOPLASTIC; CELL ADHESION; CELL MOVEMENT; DOSE-RESPONSE RELATIONSHIP, DRUG; FLOW CYTOMETRY; GLYCOCONJUGATES; HUMANS; LIVER NEOPLASMS; LUNG NEOPLASMS; MICE; MICE, INBRED C57BL; MOLECULAR SEQUENCE DATA; NEOPLASM INVASIVENESS; NEOPLASM TRANSPLANTATION; NEOPLASMS; RIBAVIRIN; TUMOR CELLS, CULTURED;

EID: 0029915380     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/0959-8049(95)00544-7     Document Type: Article

References (48)

1. Tsukamoto K, Uno A, Kubata Y, Shimada S, Hori Y, Imokawa G. Role of asparagine-linked carbohydrates in pulmonary metastasis of B16-F10 murine melanoma cells: implication through glycosylation. Inhibition of nojirimycin. Melanoma Res 1992, 2, 33-41.
2. Tímár J, Pogány G, Balázs M, et al. Modulation of membrane phenotype matrix adhesion and microinvasiveness of metastatic tumor cells by HUdR. Cell Biochem Funct 1990, 8, 211-220.
3. O'Dwyer PJ, Shoemaker DD, Jayaram HN, et al. Tiazofurin: a new antitumor agent. Invest New Drugs 1984, 2, 79-84.
4. Weber G. Critical issues in chemotherapy with tiazofurin. Adv Enz Regul 1989, 29, 75-95.
5. Tricot GJ, Jayaram HN, Nicols CR, et al. Hematological and biochemical action of tiazofurin (NSC 286193) in a case of refractory acute myeloid leukemia. Cancer Res 1987, 47, 4988-4991.
6. Jayaram HN, Pillwein K, Nichols CR, Hoffman R, Weber G. Selective sensitivity to tiazofurin of human leukemia cells. Biochem Pharmacol 1986, 35, 2029-2031.
7. Natsumeda Y, Ikegami T, Olah E, Weber G. Significance of purine salvage in circumventing the action of antimetabolites in hepatoma cells. Cancer Res 1989, 49, 88-92.
8. Robins RK, Srivastava RC, Narayanan VL. 2-β-D-ribofuranosultiazole-4-carboxamide, a novel potential antitumor agent for lung tumors and metastases. J Med Chem 1982, 25, 107-108.
9. Szekeres T, Cho-Chung YS, Weber G. Action of tiazofurin and 8-Cl-cAMP in human colon and pancreatic cancer cells. Cancer Biochem Biophys 1992, 13, 67-74.
10. Ahluwalia GS, Jayaram HN, Plowman JP. Studies on the mechanism of action of 2-β-D-furanosyltiazole-4-carboxamide. V. Factors governing the response of murine tumors to tiazofurin. Biochem Pharmacol 1984, 33, 1195-1203.
11. Lapis K, Pápay J, Paku S. Effectiveness of tiazofurin (NSC 286193) in treating disseminated tumor cells and micrometastases in mice. Oncology 1990, 47, 359-364.
12. Yamada Y, Natsumeda Y, Yamagi Y, et al. IMP dehydrogenase: inhibition of the anti-leukemic drug, tiazofurin. Leukemia Res 1989, 13, 179-184.
13. Weber G. IMP dehydrogenase and GTP as targets in human leukemia treatment. Adv Exptl Med Biol 1991, 309, 287-292.
14. Olah E, Kote Z, Natsumeda Y, et al. Down-regulation of c-myc and c-Ha-ras gene expression by tiazofurin in rat hepatoma cells. Cancer Biochem Biophys 1990, 11, 107-127.
15. Olah E, Natsumeda Y, Ikegami T, et al. Induction of erythroid differentiation and modulation of gene expression by tiazofurin in K562 leukemia cells. Proc Natl Acad Sci USA 1988, 85, 653-657.
16. Liotta LA. Tumor invasion and metastasis. Role of the extracellular matrix. Cancer Res 1986, 46, 1-7.
17. Sokoloski JA, Sartorelli AC. Effects of the inhibitors of the IMP dehydrogenase, tiazofurin and mycophenolic acid on glycoprotein metabolism. Molec Pharmacol 1985, 28, 567-573.
18. Pál K, Kopper L, Lapis K. Increased metastatic capacity of Lewis lung tumor cells by in vivo selection procedure. Invasion Metastasis 1983, 3, 174-182.
19. Paku S, Rot A, Ladányi A, Lapis K. Demonstration of organ preference of liver selected high metastatic Lewis lung tumor cell line. Clin Exp Metast 1989, 7, 599-607.
20. Lapis K, Tímár J, Pál K, Jeney A, Tímár F, Kopper L. Membrane properties of Lewis lung tumour cells with "low" and "high" metastatic capacity: anti-metastatic effect of a glycosaminoglycan biosynthesis blocking agent 5-hexyl-2-deoxyuridine (HUdR). In Cory JG, Szentiványi A, eds. Cancer Biology & Therapeutics. New York, Plenum Press, 1987, 79-94.
21. Tímár J, Moczar E, Tímár F, et al. Comparative study on Lewis lung tumor lines with low and high metastatic capacity: II. Cytochemical and biochemical differences of glycosaminoglycans. Clin Exp Metast 1987, 5, 79-87.
22. Ladányi A, Tímár J, Paku S, Molnár G, Lapis K. Selection and characterization of human melanoma lines with different liver-colonizing capacity. Int J Cancer 1990, 46, 456-461.
23. Lyon M, Gallagher JT. Purification and partial characterization of the major cell-associated heparan sulphate proteoglycan of rat liver. Biochem J 1991, 273, 415-422.
24. Honn KV, Chen YQ, Tímár J, et al. αIIbβ3 integrin expression and function in subpopulations of murine tumor. Exp Cell Res 1992, 201, 23-32.
25. Cheresh DA. Structure, function and biological properties of integrin αvβ3 on human melanoma cells. Cancer Metastasis Rev 1991, 10, 3-10.
26. Liotta LA, Stetler-Stevenson W. Metalloproteinases and malignant conversion: does correlation imply causality? J Natl Cancer Inst 1989, 81, 556-557.
27. Dennis JW, Waller C, Schirrmacher V. Identification of Asn-linked oligosaccharides involved in tumor cell adhesion to laminin and type IV collagen. J Cell Biol 1984, 99, 1416-1423.
28. Piepkorn MW, Chapman DL. Glycosaminoglycans and the substrate attachment of murine myeloma, 3T3 and cutaneous fibrosarcoma cells. Lab Invest 1985, 53, 22-29.
29. Kjellen L, Lindahl U. Proteoglycans: structures and interactions. Ann Rev Biochem 1991, 60, 443-475.
30. Bevillacqua MP. Endothelial-leukocyte adhesion molecules. Ann Rev Immunol 1993, 11, 767-804.
31. Hynes RO. Integrins: versatility, modulation and signaling in cell adhesion. Cell 1992, 69, 11-25.
32. Dennis JW, Laferté S, Waghorne C, Bretiman ML, Kerbel RS. b-1-6 branching of Asn-linked oligosaccharides is associated with metastasis. Science 1987, 236, 582-585.
33. Irimura T, Gonzales R, Nicholson GL. Effect of tunicamycin in B16 melanoma cell surface glycoproteins and blood born arrest and survival properties. Cancer Res 1981, 41, 3411-3418.
34. Lapis K, Tímár J, Jeney A. Proteoglycans as targets in the therapy of metastasis. In Huber H, Queiber W, eds. Metastasis, Basic Research and Clinical Applications, Contribution to Oncology, Vol. 44. Stuttgart-Basel, Karger, 1992, 176-184.
35. Kijima-Suda I, Miyamoto Y, Toyoshima S, Hoh M, Osawa T. Inhibition of experimental pulomonary metastasis of mouse colon adenocarcinoma 26 sublines by a sialic acid: nucleoside conjugate having sialyltransferase inhibiting activity. Cancer Res 1986, 46, 858-862.
36. Elben AD, Pan YT, Solf R, Vosteck K. Effect of swainsonine, an inhibitor of glycoprotein processing on cultured mammalian cells. J Cell Physiol 1983, 115, 265-275.
37. Peyrieras N, Bause E, Legler G, Vasilov R, Claesson L, Peterson P. Effects of glucosidase inhibitors nojirimycin and deoxynojirimycin on the biosynthesis of membrane and secretory glycoproteins. EMBO J 1983, 2, 823-832.
38. Stevens RL, Schwartz LB, Austen KF, Lohmonder S, Kimura JH. Effect of tunicamycin on insulin binding and on proteoglycan synthesis and distribution in Swarn rat chondrosarcoma cell cultures. J Biol Chem 1982, 257, 5745-5750.
39. Wich AN, Drury DR, Nakada HE, Wolfe JB. Localization of the primary metabolic block produced by 2-deoxyglucose. J Biol Chem 1957, 224, 963-973.
40. Sobue M, Habuchi H, Ito K, et al. β-Xylosides and their analogues as artificial initiators of glycosaminoglycan chain synthesis. Biochem J 1987, 241, 591-601.
41. Katoh Y, Tsui H, Matsui H, Maruta K, Morita Y. Effects of ethane-1-hydroxy-1,1-diphosphonate on cell differentiation and proteoglycan and calcium metabolism in the proximal tibia of young rats. Bone 1991, 12, 59-65.
42. De Graaf TW, Slot SS, Peters GJ, Van Dijk W. Changes in glycosylation of L1210 cells after exposure to various antimetabolites. Eur J Cancer 1993, 29A, 1760-1765.
43. De Graaf TW, Peters GJ, Van Dijk W. Antimetabolite-induced increases in the invasive capacity of murine leukemia L1210 cells. Clin Exp Metastasis 1994, 12, 134-142.
44. Albelda SM, Metta SA, Elder DE, et al. Integrin distribution in malignant melanoma; association of the β3 subunit with progression. Cancer Res 1990, 50, 6757-6764.
45. Humphries MJ, Olden K, Yamada KM. A synthetic peptide from fibronectin inhibits experimental metastasis of murine melanoma cells. Science 1986, 233, 467-470.
46. Barsky SH, Rao CN, Williams JE. Laminin molecular domains which alter metastasis in a murine model. J Clin Invest 1984, 74, 843-848.
47. Nicolson GL. Cancer metastasis: tumor cell and host organ properties important in colonization of specific secondary sites. Biochim Biophys Acta 1988, 948, 175-224.
48. Billi AM, Cocco L, Martelli AM, Gilmour RS, Weber G. Tiazofurin-induced changes in inositol lipid cycle in nuclei of Friend leukemia cells. Biochem Biophys Res Commun 1993, 195, 8-12.